artenimol has been researched along with Kahler Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Cao, W; Chen, J; Gu, H; He, J; Huang, X; Liu, Y; Qu, J; Wu, X; Xu, R; Yan, H; Zhang, E | 1 |
| Lee, J; Wu, XH; Zhou, HJ | 1 |
2 other study(ies) available for artenimol and Kahler Disease
| Article | Year |
|---|---|
Dihydroartemisinin Modulates Apoptosis and Autophagy in Multiple Myeloma through the P38/MAPK and Wnt/
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Autophagy; Cell Line, Tumor; Cell Proliferation; Humans; Male; MAP Kinase Signaling System; Mice, Inbred NOD; Models, Biological; Multiple Myeloma; p38 Mitogen-Activated Protein Kinases; Wnt Signaling Pathway | 2020 |
Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretion.
Topics: Allantoin; Angiogenesis Inhibitors; Animals; Artemisinins; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Culture Media, Conditioned; Down-Regulation; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Hypoxia; Membranes; Multiple Myeloma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Signal Transduction; Tetrazolium Salts; Thiazoles; Vascular Endothelial Growth Factor A | 2006 |